Log In
BCIQ
Print this Print this
 

Melanoma-associated antigen A3 (MAGEA3)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Melanoma-associated antigen A3 (MAGEA3)

BCIQ
Print ChartPrint this
Phase III, 1 Phase II, 2 Preclinical, 2
Phase of DevelopmentPreclinicalPhase IIPhase III
Cancer

2

2

1




 Products Targeting Melanoma-associated antigen A3 (MAGEA3)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/31/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury Trial today